Guidance: The Northern Ireland MHRA Authorised Route (NIMAR)

Medicines Healthcare Products Regulatory Agency

September 20
12:45 2022


The above provides guidance for key stakeholders in the medicines supply chain to facilitate their use of the NIMAR regulatory route for the continued supply of GB licensed medicines to NI.

Published 24 May 2022
Last updated 20 September 2022 +show all updates
  1. Added section on 'Advertising and promotions' to NIMAR guidance.

  2. First published.

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: